We conduct a thorough assessment of each patient's health history, weight loss goals, and any existing medical conditions to determine if weight loss medication is an appropriate and beneficial option for them
The pursuit of health is never entirely innocent. Ivan Illich A Timeline of Trials It began quietly in 2005 with exenatidethe first GLP-1 receptor agonist
This article explores how GLP-1 medications affect blood pressure, identifies risk factors for hypotension, and provides practical management strategies to optimize treatment outcomes
Ultimately it may turn out that different molecules may suit different patient populations and different conditions
Schmidt, MD If theres more medication in a GLP-1 injector pen than what you need for four doses, some users may think increasing their dosage will help them lose weight faster
However, it's worth noting that because A1C reflects roughly three months of average blood sugar, a 12-week study is arguably too short to capture the full effectiveness a limitation the study authors also mentioned
